(Q38170503)

30 August 2017

title

The use of endogenous T cells for adoptive transfer (English)

1 reference

30 August 2017

Cassian Yee

1

1 reference

30 August 2017

publication date

1 January 2014

1 reference

30 August 2017

published in

Immunological Reviews

1 reference

30 August 2017

volume

257

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

250-263

1 reference

Treating cancer with genetically engineered T cells

30 August 2017

cites work

1 reference

The basic principles of chimeric antigen receptor design

21 January 2018

1 reference

Engineered T cells for anti-cancer therapy.

21 January 2018

1 reference

Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo

21 January 2018

1 reference

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers

21 January 2018

1 reference

Autoreactive T cells in healthy individuals

21 January 2018

1 reference

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

21 January 2018

1 reference

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

21 January 2018

1 reference

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

21 January 2018

1 reference

Epitope landscape in breast and colorectal cancer.

21 January 2018

1 reference

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL.

21 January 2018

1 reference

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

Adoptive cell therapy for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

Guidelines for the safe administration of high-dose interleukin-2.

21 January 2018

1 reference

Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies

21 January 2018

1 reference

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

21 January 2018

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

21 January 2018

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy

21 January 2018

1 reference

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

21 January 2018

1 reference

Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype

21 January 2018

1 reference

IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response

21 January 2018

1 reference

IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.

21 January 2018

1 reference

Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environment

21 January 2018

1 reference

Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor

21 January 2018

1 reference

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

21 January 2018

1 reference

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.

21 January 2018

1 reference

Cancer immunotherapy with mRNA-transfected dendritic cells

21 January 2018

1 reference

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

21 January 2018

1 reference

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.

21 January 2018

1 reference

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules.

21 January 2018

1 reference

Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells

21 January 2018

1 reference

Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells

21 January 2018

1 reference

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma.

21 January 2018

1 reference

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

21 January 2018

1 reference

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

21 January 2018

1 reference

Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma

21 January 2018

1 reference

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

A human memory T cell subset with stem cell-like properties

21 January 2018

1 reference

Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

21 January 2018

1 reference

T cell receptor engineering

21 January 2018

1 reference

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

21 January 2018

1 reference

Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

21 January 2018

1 reference

Facilitating matched pairing and expression of TCR chains introduced into human T cells

21 January 2018

1 reference

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

21 January 2018

1 reference

IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.

21 January 2018

1 reference

Early signals during CD8 T cell priming regulate the generation of central memory cells

21 January 2018

1 reference

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

21 January 2018

1 reference

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

21 January 2018

1 reference

Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients

21 January 2018

1 reference

Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

21 January 2018

1 reference

mTOR and lymphocyte metabolism

21 January 2018

1 reference

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation

21 January 2018

1 reference

Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer

21 January 2018

1 reference

BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy

21 January 2018

1 reference

Systemic combination virotherapy for melanoma with tumor antigen-expressing vesicular stomatitis virus and adoptive T-cell transfer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IMR.12134

1 reference

30 August 2017

1 reference